Abstract:: Human embryonic stem cells (hESCs) have an enormous potential as a source for cell replacement therapies, tissue engineering, and in vitro toxicology applications. The lack of standardized and robust bioprocesses for hESC expansion has hindered the application of hESCs and their derivatives in clinical settings. We developed a robust and well-characterized bioprocess for hESC expansion under fully defined conditions and explored the potential of transcriptomic and metabolomic tools for a more comprehensive assessment of culture system impact on cell proliferation, metabolism, and phenotype. Two different hESC lines (feeder-dependent and feeder-free lines) were efficiently expanded on xeno-free microcarriers in stirred culture systems. Both hESC lines maintained the expression of stemness markers such as Oct-4, Nanog, SSEA-4, and TRA1-60 and the ability to spontaneously differentiate into the three germ layers. Whole-genome transcriptome profiling revealed a phenotypic convergence between both hESC lines along the expansion process in stirred-tank bioreactor cultures, providing strong evidence of the robustness of the cultivation process to homogenize cellular phenotype. Under low-oxygen tension, results showed metabolic rearrangement with upregulation of the glycolytic machinery favoring an anaerobic glycolysis Warburg-effect-like phenotype, with no evidence of hypoxic stress response, in contrast to two-dimensional culture. Overall, we report a standardized expansion bioprocess that can guarantee maximal product quality. Furthermore, the "omics" tools used provided relevant findings on the physiological and metabolic changes during hESC expansion in environmentally controlled stirred-tank bioreactors, which can contribute to improved scale-up production systems. Significance: The clinical application of human pluripotent stem cells (hPSCs) has been hindered by the lack of robust protocols able to sustain production of high cell numbers, as required for regenerative medicine. In this study, a strategy was developed for the expansion of human embryonic stem cells in well-defined culture conditions using microcarrier technology and stirred-tank bioreactors. The use of transcriptomic and metabolic tools allowed detailed characterization of the cell-based product and showed a phenotypic convergence between both hESC lines along the expansion process. This study provided valuable insights into the metabolic hallmarks of hPSC expansion and new information to guide bioprocess design and media optimization for the production of cells with higher quantity and improved quality, which are requisite for translation to the clinic.

Matrix-free human pluripotent stem cell manufacturing by seed train approach and intermediate cryopreservation

Human fibroblast matrices bio-assembled under macromolecular crowding support stable propagation of human embryonic stem cells.

Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture

Standardized qc assays and large scale expansion of pluripotent stem cells using an automated closed system.

Scalable expansion of human pluripotent stem cells under suspension culture condition with human platelet lysate supplementation

Feeder‐free and Xeno‐free Culture of Human Pluripotent Stem Cells Using UCBS Matrix

Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors

Investigating the feasibility of scale up and automation of human induced pluripotent stem cells cultured in aggregates in feeder free conditions

Distributed automated manufacturing of pluripotent stem cell products

Bioprocessing of Cryopreservation for Large-Scale Banking of Human Pluripotent Stem Cells

Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks

Robust Expansion of Human Pluripotent Stem Cells: Integration of Bioprocess Design With Transcriptomic and Metabolomic Characterization

Clump-passaging-based efficient 3D culture of human pluripotent stem cells under chemically defined conditions

Long‐Term Culture of Human Pluripotent Stem Cells in Xeno‐Free Condition Using Functional Polymer Films

A fully defined static suspension culture system for large-scale human embryonic stem cell production

Human Pluripotent Stem Cell Culture: Considerations for Maintenance, Expansion, and Therapeutics

Non-colony type monolayer culture of human embryonic stem cells

Adaptation to Robust Monolayer Expansion Produces Human Pluripotent Stem Cells With Improved Viability

Application-Oriented Bulk Cryopreservation of Human iPSCs in Cryo Bags Followed by Direct Inoculation in Scalable Suspension Bioreactors for Expansion and Neural Differentiation

Unlocking the Potential of Human-Induced Pluripotent Stem Cells: Cellular Responses and Secretome Profiles in Peptide Hydrogel 3D Culture

Extracellular vesicle biogenesis of three-dimensional human pluripotent stem cells in a novel Vertical-Wheel bioreactor